Zhang et al. also revealed that CDC34 positively regulates EGFR-mediated oncogenic signaling in lung cancer, and a PROTAC (proteolysis-targeting chimeras) strategy can be employed to hook small molecules to cullin-RING ligase to directly target CDC34 for degradation [113]. Here, EGFR is linked to lung cancer.